EXORPHIA is a biotech startup that develops novel medicine using extracellular vesicles.
EXORPHIA's investors include Keio Innovation Initiative, D3, Rohto Pharmaceutical.
EXORPHIA is headquartered in Otemachi, Japan.
EXORPHIA is a biotech startup that develops novel medicine using extracellular vesicles.
EXORPHIA is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EXORPHIA — Funding & Investors." VCBacked, August 20, 2025, https://www.vcbacked.co/company/exorphia. Accessed September 29, 2026.
VCBacked. (2025). EXORPHIA — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/exorphia
{{cite web |title=EXORPHIA — Funding & Investors |url=https://www.vcbacked.co/company/exorphia |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated